makers laboratories ltd (MAKR:Mumbai)
makers laboratories ltd (MAKR) Snapshot
|
Open
16.20
|
Previous Close
16.20
|
|
|
Day High
16.20
|
Day Low
16.20
|
|
|
52 Week High
01/18/13 - 24.10
|
52 Week Low
06/29/12 - 15.55
|
|
|
Market Cap
79.7M
|
Average Volume 10 Days
317.5
|
|
|
EPS TTM
-1.16
|
Shares Outstanding
4.9M
|
|
|
EX-Date
07/29/11
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
makers laboratories ltd (MAKR) Related Businessweek News
No Related Businessweek News Foundmakers laboratories ltd (MAKR) Details
Makers Laboratories Limited engages in the manufacture and sale of pharmaceuticals in India. Its principal products include chloroquine phosphates, amoxycillin trihydrates, and paracetamol tablets. The company is based in Mumbai, India.
Last Reported Date: 05/30/12
makers laboratories ltd (MAKR) Top Compensated Officers
makers laboratories ltd (MAKR) Key Developments
Makers Laboratories Ltd. reported unaudited earnings results for the third quarter and nine months ended December 31, 2012. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 143.482 million against INR 178.212 million for the same period previous year. Profit from operations before other income, finance costs and exceptional items was INR 7.532 million against INR 2.190 million for the same period of previous year. Profit from ordinary activities before tax was INR 6.618 million against INR 0.135 million for the same period of previous year. Net profit was INR 4.478 million or INR 0.91 per basic and diluted share compared to net loss INR 0.309 million or INR 0.06 per basic and diluted share for the same period of previous year. For the nine months, the company reported net sales/income from operations (net of excise duty) of INR 451.909 million against INR 499.272 million for the same period previous year. Profit from operations before other income, finance costs and exceptional items was INR 22.988 million against INR 3.182 million for the same period of previous year. Profit from ordinary activities before tax was INR 20.387 million against loss from ordinary activities before tax of INR 1.889 million for the same period of previous year. Net profit was INR 14.315 million or INR 2.91 per basic and diluted share compared to net loss INR 3.426 million or INR 0.70 per basic and diluted share for the same period of previous year.
Makers Laboratories Ltd., Board Meeting, Jan 31, 2013. Agenda: To consider quarterly results.
Makers Laboratories Ltd., Board Meeting, Oct 29, 2012. Agenda: To consider unaudited financial results for the second quarter and six months ended September 30, 2012.
| Recently Viewed | |||
| MAKR:IN | 16.20 INR | 0.00 | |
| Company | Last | Change | |
| No competitor information is available for MAKR. | |||
| View Industry Companies | |||
Industry Analysis
MAKR
Industry Average
| Valuation | MAKR | Industry Range |
| Price/Earnings | 6.7x |
|
| Price/Sales | 0.1x |
|
| Price/Book | -- | Not Meaningful |
| Price/Cash Flow | 3.6x |
|
| TEV/Sales | -- | Not Meaningful |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
To contact MAKERS LABORATORIES LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








